Rhumbline Advisers Edwards Lifesciences Corp Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

A detailed history of Rhumbline Advisers transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rhumbline Advisers holds 1,196,147 shares of EW stock, worth $78.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,196,147

Previous 1,238,520 3.42%

Holding current value

$78.3 Million

Previous $118 Million 6.64%

% of portfolio

0.11%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$84.3 - $94.31 $3.57 Million - $4 Million	-42,373 Reduced 3.42%	1,196,147 $110 Million
Q1 2024 May 09, 2024	BUY	$72.54 - $95.56 $531,210 - $699,785	7,323 Added 0.59%	1,238,520 $118 Million
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $456,777 - $575,579	-7,402 Reduced 0.6%	1,231,197 $93.9 Million
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $1.22 Million - $1.64 Million	-17,588 Reduced 1.4%	1,238,599 $85.8 Million
Q2 2023 Aug 08, 2023	BUY	$81.41 - $94.33 $799,934 - $926,886	9,826 Added 0.79%	1,256,187 $118 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $4.9 Million - $5.57 Million	65,937 Added 5.59%	1,246,361 $103 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $2.19 Million - $2.81 Million	32,133 Added 2.8%	1,180,424 $88.1 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $1.61 Million - $2.09 Million	19,525 Added 1.73%	1,148,291 $94.9 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $1.89 Million - $2.8 Million	21,812 Added 1.97%	1,128,766 $107 Million
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $3.07 Million - $3.86 Million	30,106 Added 2.8%	1,106,954 $130 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $207,421 - $254,826	-1,950 Reduced 0.18%	1,076,848 $140 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $1.17 Million - $1.4 Million	-11,416 Reduced 1.05%	1,078,798 $122 Million
Q2 2021 Aug 05, 2021	SELL	$83.84 - $104.76 $4.94 Million - $6.17 Million	-58,922 Reduced 5.13%	1,090,214 $113 Million
Q1 2021 May 06, 2021	SELL	$78.68 - $90.67 $4.04 Million - $4.65 Million	-51,321 Reduced 4.28%	1,149,136 $96.1 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $618,541 - $787,132	-8,628 Reduced 0.71%	1,200,457 $110 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $392,456 - $510,737	5,841 Added 0.49%	1,209,085 $96.5 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $45.3 Million - $60.6 Million	786,979 Added 189.06%	1,203,244 $83.2 Million
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $547,422 - $846,045	10,445 Added 2.57%	416,265 $78.5 Million
Q4 2019 Feb 05, 2020	BUY	$71.7 - $82.09 $1.62 Million - $1.86 Million	22,617 Added 5.9%	405,820 $94.7 Million
Q3 2019 Oct 23, 2019	BUY	$61.55 - $75.43 $201,576 - $247,033	3,275 Added 0.86%	383,203 $84.3 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $316,547 - $365,784	5,679 Added 1.52%	379,928 $70.2 Million
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $402,563 - $538,404	-8,406 Reduced 2.2%	374,249 $71.6 Million
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $730,586 - $896,349	-15,742 Reduced 3.95%	382,655 $58.6 Million
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $475,142 - $603,337	-10,397 Reduced 2.54%	398,397 $69.4 Million
Q2 2018 Aug 06, 2018	BUY	$42.45 - $51.3 $625,288 - $755,649	14,730 Added 3.74%	408,794 $59.5 Million
Q1 2018 May 02, 2018	SELL	$37.19 - $47.45 $384,395 - $490,443	-10,336 Reduced 2.56%	394,064 $55 Million
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $371,047 - $432,541	10,981 Added 2.79%	404,400 $45.6 Million
Q3 2017 Nov 06, 2017	BUY	$36.29 - $38.83 $14.3 Million - $15.3 Million	393,419	393,419 $43 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Edwards Lifesciences Corp Transaction History